AlphAIalphai — Financial news for AI agents
theglobeandmail.comAUG 82 min read$JHX

Oppenheimer Keeps Their Buy Rating on James Hardie Industries PLC (JHX)

Oppenheimer analyst Tyler Batory reiterated a Buy rating on James Hardie Industries PLC (JHX) and set a $36.00 price target. TipRanks cites Batory’s track record. The article also notes other analyst views (William Blair Buy, Barclays Hold) and reports JHX quarterly revenue of $1.4B and net profit of $28.5M for the quarter ended Mar. 31.

Original reporting
theglobeandmail.com
Published Aug 8, 2026, 12:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 2:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Oppenheimer Keeps Their Buy Rating on James Hardie Industries PLC (JHX) — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$JHXBullishLow
01

Why it matters

For traders, the main incremental input is the stated $36 price target tied to a reiterated Buy; it may affect short-term positioning but lacks new company-specific fundamentals.

02

Market read

A fresh sell-side price target can move expectations, but the article does not disclose new earnings, guidance, or corporate events.

03

What to watch

The article cites older earnings figures and insider buying, but does not provide new guidance, margin drivers, or demand/supply updates that would validate the $36 target.

Relevance 4/10Novelty 4/10Timing: today (analyst note reiterated and PT set)

Background

The piece summarizes an Oppenheimer analyst reiteration and includes comparative mention of other sell-side stances plus prior-quarter financials and insider buying.

Company-level read

Ticker impact

$JHXBullishMedium confidence
Context

Oppenheimer reiterated a Buy on James Hardie and set a $36 price target, adding a fresh analyst/PT catalyst for JHX.

Expected impact

Modest positive bias for JHX around the note, with limited follow-through unless supported by new company fundamentals.

Evidence & confidence

A reiterated rating plus a stated $36 target is actionable for traders, but the piece does not include new earnings, guidance, or regulatory/transactional developments.

Market effects

Sector

Reinforces positive sentiment toward consumer cyclicals/housebuilding-related names, but provides no sector-wide new data.

Regional

No specific regional market linkage beyond general sentiment.

Global

No global macro or cross-border transaction details.

Counterpoint

What could challenge this read

Barclays maintained a Hold as of July 24, suggesting disagreement and potential resistance to sustained upside from the Oppenheimer note alone.

Key entities

  • company
    James Hardie Industries PLC

    Subject of the analyst reiteration, with Oppenheimer setting a $36 price target and noting prior-quarter results and insider buying.

  • analyst_firm
    Oppenheimer

    Reiterated Buy rating and set the $36 price target in the report referenced by the article.

  • analyst_firm
    Barclays

    Maintained a Hold rating on JHX as of July 24, cited as a counterpoint.

Read at source← All news

Related articles

AUG 24
$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

investing.com3 min
AUG 21
$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

rte.ie2 min
AUG 21
$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

afr.com1 min
AUG 20
$JHXHighAI 9/10

James Hardie Selling European Fermacell Business for $980 Million to Holcim

James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.

morningstar.com2 min
AUG 20
$JHXHighAI 9/10

James Hardie Industries plc: James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million

James Hardie (JHX) is selling its European operations, including Fermacell, to Holcim (HOLN) for €840 million. The company will also close its European fiber cement business. Proceeds will be used to repay debt and fund a $250 million share buyback program. The deal is expected to close in early 2027.

finanznachrichten.de3 min